NCT02155010

Brief Summary

Patients were randomized into two groups, A group and B group. A group and B group patients are injected intravenous dexmedetomidine after intrathecal injection (IT) of heavy bupivacaine and injected intravenous dexmedetomidine before IT of heavy bupivacaine, respectively. The investigators will compare of hemodynamics and patient's comfortability between two groups.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
74

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2014

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2014

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

May 22, 2014

Completed
13 days until next milestone

First Posted

Study publicly available on registry

June 4, 2014

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2015

Completed
1.2 years until next milestone

Results Posted

Study results publicly available

September 26, 2016

Completed
Last Updated

September 26, 2016

Status Verified

August 1, 2016

Enrollment Period

1.3 years

First QC Date

May 22, 2014

Results QC Date

December 10, 2015

Last Update Submit

August 3, 2016

Conditions

Keywords

DexmedetomidineSpinal anesthesia

Outcome Measures

Primary Outcomes (1)

  • Incidence of Hypotension

    We compare incidence rate of hypotension during infusion of dexmedetomidine

    up to 3 hours

Secondary Outcomes (1)

  • Patient's Anxiety

    up to 3 days

Study Arms (2)

Dexmedetomidine

EXPERIMENTAL

IV dexmedetomidine infusion before intrathecal injection of heavy bupivacaine

Drug: Dexmedetomidine

Dexmedetomidine with heavy bupivacaine

ACTIVE COMPARATOR

IV dexmedetomidine infusion after intrathecal injection of heavy bupivacaine

Drug: Dexmedetomidine with heavy bupivacaine

Interventions

Dexmedetomidine infusion before intrathecal injection of heavy bupivacaine

Also known as: Precedex
Dexmedetomidine

Dexmedetomidine infusion after IT of heavy bupivacaine

Also known as: Precedex, Marcaine
Dexmedetomidine with heavy bupivacaine

Eligibility Criteria

Age20 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • aged patients
  • orthopedic operation undergoing spinal anesthesia

You may not qualify if:

  • more than American society of anesthesiologists classification 3
  • hypertension
  • diabetes mellitus
  • heart disease (bradycardia, atrioventricular block)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Inje University, Haeundae paik hospital

Busan, 612-896, South Korea

Location

Related Publications (1)

  • Kang E, Lee KH, Jeon SY, Lee KW, Ko MJ, Kim H, Kim YH, Jung JW. The timing of administration of intravenous dexmedetomidine during lower limb surgery: a randomized controlled trial. BMC Anesthesiol. 2016 Nov 21;16(1):116. doi: 10.1186/s12871-016-0282-2.

MeSH Terms

Conditions

Anxiety Disorders

Interventions

DexmedetomidineBupivacaine

Condition Hierarchy (Ancestors)

Mental Disorders

Intervention Hierarchy (Ancestors)

ImidazolesAzolesHeterocyclic Compounds, 1-RingHeterocyclic CompoundsAnilidesAmidesOrganic ChemicalsAniline CompoundsAmines

Limitations and Caveats

We did not assess the differences among the groups regarding postoperative analgesic consumption and the duration of sensory or motor bloakade produced by spinal anesthesia with dexmedetomidine infusion.

Results Point of Contact

Title
Ki Hwa Lee
Organization
Haeundae paik hospital, Inje University

Study Officials

  • Ki Hwa Lee, MD

    Inje University Haeundae Paik Hospital

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant professor

Study Record Dates

First Submitted

May 22, 2014

First Posted

June 4, 2014

Study Start

March 1, 2014

Primary Completion

July 1, 2015

Study Completion

July 1, 2015

Last Updated

September 26, 2016

Results First Posted

September 26, 2016

Record last verified: 2016-08

Data Sharing

IPD Sharing
Will share

De-identified individual participant data for all primary and secondary outcome measures will be made available within 3 years of study completion.

Locations